Home/Filings/4/0001104659-25-023724
4//SEC Filing

WEAVER GREGORY L 4

Accession 0001104659-25-023724

CIK 0001326190other

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 7:27 AM ET

Size

5.4 KB

Accession

0001104659-25-023724

Insider Transaction Report

Form 4
Period: 2025-03-13
WEAVER GREGORY L
Chief Financial Officer
Transactions
  • Purchase

    Common Stock, par value $0.0001

    2025-03-13$5.20/sh+10,000$51,99610,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.1950 to $5.1997, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Issuer

Altimmune, Inc.

CIK 0001326190

Entity typeother

Related Parties

1
  • filerCIK 0001251779

Filing Metadata

Form type
4
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 7:27 AM ET
Size
5.4 KB